How medicines interact: a plain-language overview

A medicine interaction occurs when the effect of a medicine is altered by the presence of another substance in the body. Medicines are carefully designed to produce specific effects, but they rarely act in complete isolation. When a person takes multiple medicines, dietary supplements, or even certain foods at the same time, these substances can influence one another. The result might be that a medicine works too strongly, not strongly enough, or produces an unexpected side effect. As people increasingly take multiple medicines simultaneously—a situation often referred to as polypharmacy—understanding how these interactions occur has become an essential component of safe medicine management.

What is a medicine interaction?

Interactions are generally grouped by what is interacting with the medicine. The most common type is a drug-drug interaction, which happens when two different medicines affect each other's behaviour. Beyond other medicines, interactions can also occur with food or drinks. For example, grapefruit juice is widely known to interfere with the enzymes that process several types of medicines, potentially leading to higher-than-expected levels of the medicine in the blood. Additionally, a drug-condition interaction can happen when an existing health issue, such as reduced liver or kidney function, changes how a medicine is handled by the body. Interactions are often classified by severity. Some are minor and cause little to no discomfort, while others are clinically significant and require a change in treatment to prevent harm. Not all interactions are inherently dangerous; many are predictable and can be managed by a healthcare professional through careful monitoring.

Pharmacokinetic interactions

Pharmacokinetics is the study of what the body does to a medicine. This process involves four main steps: absorption, distribution, metabolism, and excretion. A pharmacokinetic interaction happens when one substance interferes with one of these steps. Many pharmacokinetic interactions occur in the liver, where a group of enzymes known as the cytochrome P450 system breaks down medicines. If one medicine inhibits these enzymes, another medicine taken at the same time might build up to unsafe levels in the bloodstream because it is not being broken down efficiently. Conversely, if a medicine induces or speeds up these enzymes, the second medicine might be broken down too quickly, reducing its effectiveness. Interactions can also happen in the kidneys. If two medicines compete for the same excretion pathway, one might be removed from the body much slower than usual, prolonging its action.

Pharmacodynamic interactions

Pharmacodynamics is the study of what the medicine does to the body. A pharmacodynamic interaction occurs when two medicines have similar or opposing effects on the body's biological systems, often acting on the same receptors or pathways. Unlike pharmacokinetic interactions, the blood levels of the medicines remain unchanged, but the physical response is altered. If two medicines cause drowsiness, taking them together can lead to an additive effect, making the drowsiness much stronger than it would be from either medicine alone. This is a common issue when combining certain sleeping tablets, antihistamines, and strong painkillers. Conversely, an antagonistic interaction happens when one medicine blocks or reduces the effect of another. For example, a medicine designed to lower blood pressure might be less effective if taken alongside a different medicine that raises blood pressure as a side effect.

Checking for interactions and the role of the package insert

Because the potential for interactions is vast, pharmacists and prescribers routinely check a patient's medicine profile before a new medicine is dispensed. They often use specialised clinical software to cross-reference new prescriptions against existing ones, screening for known interactions based on established severity. The official package insert included in every medicine box serves as a critical tool in this process. In South Africa, the package insert is approved by the South African Health Products Regulatory Authority (SAHPRA) and contains a specific section dedicated to listing known interactions. The insert provides the technical details that pharmacists use to determine whether a potential interaction is clinically significant. When a significant interaction is flagged, the healthcare provider may contact the prescriber to discuss an alternative medicine or counsel the patient on safe usage and timing.